Pancreatic cancer has the worst survival rate of any solid tumor. Because symptoms of pancreatic cancer can be subtle, the majority of patients are diagnosed with advanced disease. Many of these patients are treated in the community oncology setting. Physicians in the community must be able to optimize current available therapies (surgery, radiation, chemotherapy, and molecular targeted). Treatment optimization requires an accurate understanding of the disease state in the adjuvant and metastatic settings. Treatment optimization also includes an understanding of how to provide palliative care to patients with advanced pancreatic cancer.

CME LLC has collaborated with a team of oncology and hematology specialists to provide insight into currently unresolved treatment dilemmas. In New Treatment Paradigms in Pancreatic Cancer, these experts write about recent advances that are pertinent for oncology practice, and provide a reasoned and practical perspective that may advance patient care.

CME, 3 Credits    Nov 12, 2009

The prevalence of pain and inadequate analgesia in patients with cancer is well documented. Pain management is frequently necessary in cancer treatment, making it critical that those treating the cancer patient completely understand how to correctly assess the pain and determine the proper type of treatment.

CME LLC has collaborated with a team of oncology specialists in the field of pain management. In Managing Cancer Pain: A Bedside Approach, these experts discuss recent advances that are pertinent for oncology practice, and provide a seasoned and practical perspective that may advance patient care.

CME, 1 Credits    Oct 01, 2009

This activity is based on review articles in the journal ONCOLOGY. It is developed from an identified educational need for information about practical management issues in the practice of medical, surgical, and radiation oncology. This activity has been developed and approved under the direction of CME LLC.

CME, 3 Credits    Sep 15, 2009

This activity is based on review articles in the journal ONCOLOGY. It is developed from an identified educational need for information about practical management issues in the practice of medical, surgical, and radiation oncology. This activity has been developed and approved under the direction of CME LLC.

CME, 3 Credits    Aug 15, 2009

This monthly journal features clinical and practical review articles in medical, hematological, surgical and radiation oncology with solicited articles by leading authorities supplemented by two or three peer review commentaries. This issue discusses: optimal initial treatment of low-risk papillary thyroid cancer and patient perceptions; prophylactic central lymph node dissection; Lymphoma; Prostate Cancer and LHRH antagonists vs. LHRH antagonists; ‘natural’ hormone replacement and breast cancer risk; phase IIIB Trial of intermittent degarelix therapy, FDA and talactoferrin/sunitinib for renal cell carcinoma, ACLU challenges patents on breast cancer genes; reports from ASCO: maintenance therapy with pemetrexed in advanced NSCLC, PARP inhibitors for breast cancers, therapeutic cancer vaccine for follicular lymphoma, vaccine in metastatic melanoma; and music therapy

CME, 3 Credits    Jun 15, 2009